Inflammation and immunity in diabetic vascular complications.
(2008) In Current Opinion in Lipidology 19(5). p.519-524- Abstract
- PURPOSE OF REVIEW: Diabetes is associated with an increased risk for cardiovascular disease. The purpose of this review is to discuss possible mechanisms through which diabetes can contribute to a more aggressive atherosclerotic disease process with a particular focus on the role of innate and adaptive immunity. RECENT FINDINGS: The observation that adaptive immune responses to oxidized LDL modulate atherosclerotic plaque development has led to development of pilot vaccines that inhibit atherosclerosis in experimental animals. Recent studies have shown that similar immune responses operate against self-antigens modified by glycation in diabetes. Diabetes has also been shown to activate proinflammatory innate immune receptors and... (More)
- PURPOSE OF REVIEW: Diabetes is associated with an increased risk for cardiovascular disease. The purpose of this review is to discuss possible mechanisms through which diabetes can contribute to a more aggressive atherosclerotic disease process with a particular focus on the role of innate and adaptive immunity. RECENT FINDINGS: The observation that adaptive immune responses to oxidized LDL modulate atherosclerotic plaque development has led to development of pilot vaccines that inhibit atherosclerosis in experimental animals. Recent studies have shown that similar immune responses operate against self-antigens modified by glycation in diabetes. Diabetes has also been shown to activate proinflammatory innate immune receptors and intracellular oxidative stress. SUMMARY: There are many similarities between the autoimmune responses against oxidized LDL and proteins modified by glycation. The role of autoimmune responses against modified self-antigens in the development of diabetic vascular complications represents a relatively unexplored concept that potentially could provide significant new mechanistic insight into the underlying disease process and identify novel targets for intervention. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1243413
- author
- Nilsson, Jan LU ; Bengtsson, Eva LU ; Nordin Fredrikson, Gunilla LU and Björkbacka, Harry LU
- organization
- publishing date
- 2008
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Current Opinion in Lipidology
- volume
- 19
- issue
- 5
- pages
- 519 - 524
- publisher
- Lippincott Williams & Wilkins
- external identifiers
-
- wos:000259349800012
- pmid:18769234
- scopus:53549101280
- pmid:18769234
- ISSN
- 1473-6535
- DOI
- 10.1097/MOL.0b013e32830f47cd
- language
- English
- LU publication?
- yes
- id
- 336a809b-87ef-44d2-89d0-151d7a19224c (old id 1243413)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/18769234?dopt=Abstract
- date added to LUP
- 2016-04-04 07:59:56
- date last changed
- 2022-01-29 02:54:28
@article{336a809b-87ef-44d2-89d0-151d7a19224c, abstract = {{PURPOSE OF REVIEW: Diabetes is associated with an increased risk for cardiovascular disease. The purpose of this review is to discuss possible mechanisms through which diabetes can contribute to a more aggressive atherosclerotic disease process with a particular focus on the role of innate and adaptive immunity. RECENT FINDINGS: The observation that adaptive immune responses to oxidized LDL modulate atherosclerotic plaque development has led to development of pilot vaccines that inhibit atherosclerosis in experimental animals. Recent studies have shown that similar immune responses operate against self-antigens modified by glycation in diabetes. Diabetes has also been shown to activate proinflammatory innate immune receptors and intracellular oxidative stress. SUMMARY: There are many similarities between the autoimmune responses against oxidized LDL and proteins modified by glycation. The role of autoimmune responses against modified self-antigens in the development of diabetic vascular complications represents a relatively unexplored concept that potentially could provide significant new mechanistic insight into the underlying disease process and identify novel targets for intervention.}}, author = {{Nilsson, Jan and Bengtsson, Eva and Nordin Fredrikson, Gunilla and Björkbacka, Harry}}, issn = {{1473-6535}}, language = {{eng}}, number = {{5}}, pages = {{519--524}}, publisher = {{Lippincott Williams & Wilkins}}, series = {{Current Opinion in Lipidology}}, title = {{Inflammation and immunity in diabetic vascular complications.}}, url = {{http://dx.doi.org/10.1097/MOL.0b013e32830f47cd}}, doi = {{10.1097/MOL.0b013e32830f47cd}}, volume = {{19}}, year = {{2008}}, }